| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Yu Ling Chan CEO | HKEX Exchange | G7306Y104 CUSIP |
| Hong Kong Country | 525 Employees | - Last Dividend | 29 Jan 2020 Last Split | - IPO Date |
PuraPharm Corporation Limited, established in 1998 and headquartered in Tai Po, Hong Kong, stands as a pioneering entity in the realm of traditional Chinese medicine (TCM). This investment holding company dedicates itself to the research, development, production, and distribution of Concentrated Chinese Medicine Granule (CCMG) and a range of Chinese healthcare products. Operating across Mainland China, Hong Kong, and international markets, PuraPharm has segmented its operations into five distinct areas: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation.
The company has made its mark by offering a variety of over-the-counter health products under reputable names such as PuraGold, Oncozac, Haveron, and Immuzac. Additionally, PuraPharm has embraced technological solutions through the provision of a Chinese medicine clinic management system designed for streamlining general clinic operations. Its chain of Nong’s clinics offers professional Chinese medicine services and concentrated Chinese medicine granules products, embodying the synergy between tradition and modernized healthcare.
PuraPharm's endeavors extend to the cultivation and commercial trading of raw Chinese herbs and the manufacturing plus sale of traditional Chinese medicine decoction pieces. These ventures underscore the company’s dedication to preserving the authenticity of TCM while incorporating modern practices for enhanced accessibility and efficacy. Committed to serving a broad audience, their products find their way to hospitals, healthcare institutions, medicine practitioners, and consumers through an innovative online store, illustrating PuraPharm's strategy to intertwine traditional remedies with modern-day convenience and reach.
PuraPharm specializes in researching, developing, and producing a wide range of CCMG products. These granules are designed for both efficacy and convenience, offering a modern approach to traditional Chinese medicine formulations.
Under renowned brands like PuraGold, Oncozac, Haveron, and Immuzac, the company offers health supplements and products aimed at improving general wellness, immune function, hair growth, and supporting cancer care.
Tailored for optimizing the operations of Chinese medicine clinics, this system facilitates appointment scheduling, patient management, inventory control, and overall clinic workflow.
These clinics provide a comprehensive range of Chinese medicine services including consultations, acupuncture, and tailor-made prescriptions of CCMG. They stand as a testament to PuraPharm's commitment to integrating traditional Chinese medicine into modern healthcare settings.
Engaging in sustainable cultivation methods, PuraPharm ensures a steady supply of high-quality raw Chinese herbs. This vertical integration strategy enables the company to maintain strict quality control from source to product.
The processing and sale of these decoction pieces further demonstrate PuraPharm’s dedication to offering authentic TCM products. These pieces are prepared following traditional methods, ensuring that they retain their therapeutic effectiveness.
PuraPharm has positioned itself at the forefront of modernized TCM by offering advanced diagnostic services and treatment options. This includes leveraging the latest in medical technologies and methodologies to provide personalized and effective healthcare solutions.
Recognizing the importance of accessibility, PuraPharm operates an online store, offering their extensive range of TCM products and healthcare solutions to a global audience, thereby expanding the reach of traditional Chinese medicine.